OPERATIONS CONTINUE: CONTINGENCY PLANS IN PLACE
Despite the circumstances due to COVID-19, ICCBBA has contingency plans in place to operate effectively.
top of page
Search
Mar 12, 2020
UPDATE: DRAFT PUBLICATION CLOSED FOR COMMENTARY
Open for commentary: "Standard Labeling for Apheresis Collection Products for Sponsor Cellular Therapy Manufacturing"
Mar 3, 2020
NEW PRODUCT DESCRIPTION CODES FOR COVID-19 CONVALESCENT PLASMA
In response to requests from blood transfusion services in Singapore and the UK ICCBBA has fast-tracked the release of new product descripti
Dec 2, 2019
CLOSED: TECHNICAL DIRECTOR
ICCBBA are recruiting a Technical Director to oversee the development and maintenance of the ISBT 128 Standard. The position is...
Oct 4, 2019
CELLULAR THERAPY AUDIT TOOL
This tool is intended for auditors to help them assess compliance to ISBT 128 requirements for cellular therapy products. The audit tool...
Oct 2, 2019
REGISTERED FACILITIES DATABASE HAS BEEN UPDATED
The Registered Facilities Database has been updated and is now available to licensed facilities. The database contains the names and...
Jul 22, 2019
ICCBBA ONE WORLD AWARD RECIPIENTS - 2019
ICCBBA is proud to announce Ms. Suzanne H. Butch and Dr. Jørgen Georgsen as our two recipients of the 2019 One World Award. The ICCBBA...
Dec 28, 2018
SPECIAL TESTING GENERAL DATABASE
ICCBBA recognizes the growing need for facilities to be able to differentiate their blood component units that have been tested for the...
Oct 5, 2018
NEW PRODUCT LOOKUP WEB APPLICATION
New Product Lookup Web Application available now!
bottom of page